| 1 | [SID49731821] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 2 | [SID49731821] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 3 | [SID49731821] | Inactive | Potency | 0.0083 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | 0.0083 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID49731821] | Inactive | Potency | 28.1838 | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding [AID2675, Type: confirmatory] | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding | | AID | 2675 | | BioAssay type | confirmatory | | Target | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] | | PubMed | | | Data Table |  |
|
| 5 | [SID49731821] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 6 | [SID49731821] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 7 | [SID49731821] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 8 | [SID49731821] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 9 | [SID49731821] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 10 | [SID49731821] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 11 | [SID49731821] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 12 | [SID49731821] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 13 | [SID49731821] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 14 | [SID49731821] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 15 | [SID49731821] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 16 | [SID49731821] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 17 | [SID49731821] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide [AID1766, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide | | AID | 1766 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 18 | [SID49731821] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 19 | [SID49731821] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 20 | [SID49731821] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 21 | [SID49731821] | Inactive | Potency | | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction [AID2662, Type: confirmatory] | MLL gene product [Homo sapiens] [gi:56550039] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction | | AID | 2662 | | BioAssay type | confirmatory | | Target | MLL gene product [Homo sapiens] [gi:56550039] | | PubMed | | | Data Table |  |
|
| 22 | [SID49731821] | Inactive | | | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity [AID651704, Type: screening] | MLLT3 gene product [Homo sapiens] [gi:156104889] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651704 | | BioAssay type | screening | | Target | MLLT3 gene product [Homo sapiens] [gi:156104889] | | PubMed | | | Data Table |  |
|
| 23 | [SID49731821] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 24 | [SID49731821] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 25 | [SID49731821] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 26 | [SID49731821] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 27 | [SID49731821] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 28 | [SID49731821] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 29 | [SID49731821] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 30 | [SID49731821] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 31 | [SID49731821] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 32 | [SID49731821] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 33 | [SID49731821] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 34 | [SID49731821] | Inactive | Potency | | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 35 | [SID49731821] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 36 | [SID49731821] | Inactive | | | Image-Based HTS for Selective Agonists for NTR1 [AID493036, Type: screening] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Image-Based HTS for Selective Agonists for NTR1 | | AID | 493036 | | BioAssay type | screening | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 37 | [SID49731821] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 38 | [SID49731821] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 39 | [SID49731821] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 40 | [SID49731821] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 41 | [SID49731821] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 42 | [SID49731821] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 43 | [SID49731821] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 44 | [SID49731821] | Inactive | IC50 | | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1778, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1778 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 45 | [SID49731821] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 46 | [SID49731821] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 47 | [SID49731821] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 48 | [SID49731821] | Inactive | EC50 | | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay [AID1777, Type: confirmatory] | kappa-type opioid receptor [Homo sapiens] [gi:39725940] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay | | AID | 1777 | | BioAssay type | confirmatory | | Target | kappa-type opioid receptor [Homo sapiens] [gi:39725940] | | PubMed | | | Data Table |  |
|
| 49 | [SID49731821] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 50 | [SID49731821] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). [AID2435, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49731821 | | CID | 20903580 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). | | AID | 2435 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|